BBOT insider trades & SEC filings
The most recent insider transactions at BridgeBio Oncology Therapeutics, Inc., parsed from SEC Form 3, 4, and 5 filings. Each row links back to the original filing on EDGAR.
Buys, last 90d
0
Sells, last 90d
0
Trades shown
14
Counts are computed from the 14 most recent trades shown below.
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Cobo Marc | Principal Accounting Officer | other | 125 | $7.80 | $975 | 4 on EDGAR |
| Jul 1, 2026 | Ben Yong | Chief Med & Dev Officer | other | 1,047 | $7.80 | $8,167 | 4 on EDGAR |
| Jul 1, 2026 | Beltran Pedro | President and CEO | other | 1,047 | $7.80 | $8,167 | 4 on EDGAR |
| Jul 1, 2026 | Elmelech Idan | COO & Principal Financial Ofcr | other | 343 | $7.80 | $2,675 | 4 on EDGAR |
| Jul 1, 2026 | Chen Bihua | Insider | other | 4,528,186 | $0.00 | $0 | 4 on EDGAR |
| Jun 16, 2026 | MCCORMICK FRANK | Director | grant | 31,675 | — | — | 4 on EDGAR |
| Jun 16, 2026 | Tipirneni Praveen P. | Director | grant | 31,675 | — | — | 4 on EDGAR |
| Jun 16, 2026 | Kumar Neil | Director | grant | 31,675 | — | — | 4 on EDGAR |
| Jun 16, 2026 | Kelleher Raymond J. | Director | grant | 31,675 | — | — | 4 on EDGAR |
| Jun 16, 2026 | Lebowitz Peter F | Director | grant | 7,289 | — | — | 4 on EDGAR |
| Jun 16, 2026 | Chen Bihua | Director, 10% owner | grant | 31,675 | — | — | 4 on EDGAR |
| May 10, 2026 | Beltran Pedro | President and CEO | grant | 1,103,837 | — | — | 4 on EDGAR |
| May 10, 2026 | Elmelech Idan | COO & Principal Financial Ofcr | grant | 758,222 | — | — | 4 on EDGAR |
| — | Cobo Marc | Principal Accounting Officer | — | — | — | — | 3 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Get the data
Query BBOT filings like a database.
These trades come from the QuantConomy SEC filings API, also available to AI agents over MCP. Join the waitlist for early access.